- call +1-201-465-4211
- email sales@mrinsights.biz
Dry eye disease is a condition that affects the tear film and ocular surface. It is medically known as keratoconjunctivitis sicca. It is an ocular disorder caused by the lack of tear fluid to lubricate the eyes. There are primarily two types of dry eye conditions. One is aqueous tear-deficient dry eye, and the other one is evaporative dry eye. Dry eye syndrome is one of the most common eye disorders around the world and is particularly common in the geriatric demographic. Reduction in the production of tears due to aging is the primary cause of dry eye syndrome among the elderly.
Scope of the Report:
North America dominates the global market. The region is projected to account for a significant share of the global dry eye drugs and devices treatment market during the forecast period due to a high incidence of dry eye disease among the American population.
The global Dry Eye Drugs and Devices Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Dry Eye Drugs and Devices Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Dry Eye Drugs and Devices Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Dry Eye Drugs and Devices Treatment market by product type and applications/end industries.
Market Segment by Companies, this report covers
Novartis
Merck
Johnson & Johnson
EyeGate Pharmaceuticals
Allergan
Shire
Jianfeng Group
Valeant Pharmaceuticals
Santen Pharmaceutical
Senju Pharmaceutical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Antibiotic Drops
Hormone Drops
Artificial Tears
Others
Market Segment by Applications, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Dry Eye Drugs and Devices Treatment Market Overview
1.1 Product Overview and Scope of Dry Eye Drugs and Devices Treatment
1.2 Classification of Dry Eye Drugs and Devices Treatment by Types
1.2.1 Global Dry Eye Drugs and Devices Treatment Revenue Comparison by Types (2017-2023)
1.2.2 Global Dry Eye Drugs and Devices Treatment Revenue Market Share by Types in 2017
1.2.3 Antibiotic Drops
1.2.4 Hormone Drops
1.2.5 Artificial Tears
1.2.6 Others
1.3 Global Dry Eye Drugs and Devices Treatment Market by Application
1.3.1 Global Dry Eye Drugs and Devices Treatment Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Dry Eye Drugs and Devices Treatment Market by Regions
1.4.1 Global Dry Eye Drugs and Devices Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Dry Eye Drugs and Devices Treatment Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Dry Eye Drugs and Devices Treatment Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Dry Eye Drugs and Devices Treatment Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Dry Eye Drugs and Devices Treatment Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Dry Eye Drugs and Devices Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Dry Eye Drugs and Devices Treatment (2013-2023)
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Business Overview
2.1.2 Dry Eye Drugs and Devices Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Novartis Dry Eye Drugs and Devices Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 Merck
2.2.1 Business Overview
2.2.2 Dry Eye Drugs and Devices Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merck Dry Eye Drugs and Devices Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Johnson & Johnson
2.3.1 Business Overview
2.3.2 Dry Eye Drugs and Devices Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Johnson & Johnson Dry Eye Drugs and Devices Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 EyeGate Pharmaceuticals
2.4.1 Business Overview
2.4.2 Dry Eye Drugs and Devices Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 EyeGate Pharmaceuticals Dry Eye Drugs and Devices Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 Allergan
2.5.1 Business Overview
2.5.2 Dry Eye Drugs and Devices Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Allergan Dry Eye Drugs and Devices Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.6 Shire
2.6.1 Business Overview
2.6.2 Dry Eye Drugs and Devices Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Shire Dry Eye Drugs and Devices Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.7 Jianfeng Group
2.7.1 Business Overview
2.7.2 Dry Eye Drugs and Devices Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Jianfeng Group Dry Eye Drugs and Devices Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.8 Valeant Pharmaceuticals
2.8.1 Business Overview
2.8.2 Dry Eye Drugs and Devices Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Valeant Pharmaceuticals Dry Eye Drugs and Devices Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.9 Santen Pharmaceutical
2.9.1 Business Overview
2.9.2 Dry Eye Drugs and Devices Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Santen Pharmaceutical Dry Eye Drugs and Devices Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.10 Senju Pharmaceutical
2.10.1 Business Overview
2.10.2 Dry Eye Drugs and Devices Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Senju Pharmaceutical Dry Eye Drugs and Devices Treatment Revenue, Gross Margin and Market Share (2016-2017)
3 Global Dry Eye Drugs and Devices Treatment Market Competition, by Players
3.1 Global Dry Eye Drugs and Devices Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Dry Eye Drugs and Devices Treatment Players Market Share
3.2.2 Top 10 Dry Eye Drugs and Devices Treatment Players Market Share
3.3 Market Competition Trend
4 Global Dry Eye Drugs and Devices Treatment Market Size by Regions
4.1 Global Dry Eye Drugs and Devices Treatment Revenue and Market Share by Regions
4.2 North America Dry Eye Drugs and Devices Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Dry Eye Drugs and Devices Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Dry Eye Drugs and Devices Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Dry Eye Drugs and Devices Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Dry Eye Drugs and Devices Treatment Revenue and Growth Rate (2013-2018)
5 North America Dry Eye Drugs and Devices Treatment Revenue by Countries
5.1 North America Dry Eye Drugs and Devices Treatment Revenue by Countries (2013-2018)
5.2 USA Dry Eye Drugs and Devices Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Dry Eye Drugs and Devices Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Dry Eye Drugs and Devices Treatment Revenue and Growth Rate (2013-2018)
6 Europe Dry Eye Drugs and Devices Treatment Revenue by Countries
6.1 Europe Dry Eye Drugs and Devices Treatment Revenue by Countries (2013-2018)
6.2 Germany Dry Eye Drugs and Devices Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Dry Eye Drugs and Devices Treatment Revenue and Growth Rate (2013-2018)
6.4 France Dry Eye Drugs and Devices Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Dry Eye Drugs and Devices Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Dry Eye Drugs and Devices Treatment Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Dry Eye Drugs and Devices Treatment Revenue by Countries
7.1 Asia-Pacific Dry Eye Drugs and Devices Treatment Revenue by Countries (2013-2018)
7.2 China Dry Eye Drugs and Devices Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Dry Eye Drugs and Devices Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Dry Eye Drugs and Devices Treatment Revenue and Growth Rate (2013-2018)
7.5 India Dry Eye Drugs and Devices Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Dry Eye Drugs and Devices Treatment Revenue and Growth Rate (2013-2018)
8 South America Dry Eye Drugs and Devices Treatment Revenue by Countries
8.1 South America Dry Eye Drugs and Devices Treatment Revenue by Countries (2013-2018)
8.2 Brazil Dry Eye Drugs and Devices Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Dry Eye Drugs and Devices Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Dry Eye Drugs and Devices Treatment Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Dry Eye Drugs and Devices Treatment by Countries
9.1 Middle East and Africa Dry Eye Drugs and Devices Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Dry Eye Drugs and Devices Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Dry Eye Drugs and Devices Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Dry Eye Drugs and Devices Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Dry Eye Drugs and Devices Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Dry Eye Drugs and Devices Treatment Revenue and Growth Rate (2013-2018)
10 Global Dry Eye Drugs and Devices Treatment Market Segment by Type
10.1 Global Dry Eye Drugs and Devices Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Dry Eye Drugs and Devices Treatment Market Forecast by Type (2018-2023)
10.3 Antibiotic Drops Revenue Growth Rate (2013-2023)
10.4 Hormone Drops Revenue Growth Rate (2013-2023)
10.5 Artificial Tears Revenue Growth Rate (2013-2023)
10.6 Others Revenue Growth Rate (2013-2023)
11 Global Dry Eye Drugs and Devices Treatment Market Segment by Application
11.1 Global Dry Eye Drugs and Devices Treatment Revenue Market Share by Application (2013-2018)
11.2 Dry Eye Drugs and Devices Treatment Market Forecast by Application (2018-2023)
11.3 Hospital Pharmacies Revenue Growth (2013-2018)
11.4 Retail Pharmacies Revenue Growth (2013-2018)
11.5 Online Pharmacies Revenue Growth (2013-2018)
12 Global Dry Eye Drugs and Devices Treatment Market Size Forecast (2018-2023)
12.1 Global Dry Eye Drugs and Devices Treatment Market Size Forecast (2018-2023)
12.2 Global Dry Eye Drugs and Devices Treatment Market Forecast by Regions (2018-2023)
12.3 North America Dry Eye Drugs and Devices Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Dry Eye Drugs and Devices Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Dry Eye Drugs and Devices Treatment Revenue Market Forecast (2018-2023)
12.6 South America Dry Eye Drugs and Devices Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Dry Eye Drugs and Devices Treatment Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Dry Eye Drugs and Devices Treatment Picture
Table Product Specifications of Dry Eye Drugs and Devices Treatment
Table Global Dry Eye Drugs and Devices Treatment and
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
